Literature DB >> 2696218

The endocrine basis of benign breast disorders.

L Dogliotti, F Orlandi, A Angeli.   

Abstract

There is sound clinical evidence that many benign breast conditions, especially pain, nodularity, and cysts, are likely to have their pathogenesis in hormonal events during reproductive life. Yet the classical theories of persisting hyperestrogenism and luteal progestogen deficiency have not stood up to detailed investigation. Recent work has demonstrated the importance of dynamic hormonal changes and of chronobiological rhythms--daily, menstrual, and seasonal. Recent developments and findings are reviewed to point to the directions in which the basic etiology of these conditions is likely to be discovered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2696218     DOI: 10.1007/BF01658413

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  42 in total

1.  Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study.

Authors:  D Beccati; N Grilli; P Schincaglia; C Naldoni; L Tavolazzi; R Ranaldi; L Dogliotti; M Torta; A Angeli
Journal:  Eur J Cancer Clin Oncol       Date:  1988-04

2.  Serum progesterone concentration during the luteal phase in women with benign breast disease.

Authors:  P V Walsh; R D Bulbrook; P M Stell; D Y Wang; I W McDicken; W D George
Journal:  Eur J Cancer Clin Oncol       Date:  1984-11

3.  Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.

Authors:  B Tarquini; R Gheri; S Romano; A Costa; M Cagnoni; J K Lee; F Halberg
Journal:  Am J Med       Date:  1979-02       Impact factor: 4.965

4.  Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.

Authors:  W B Malarkey; L L Schroeder; V C Stevens; A G James; R R Lanese
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

5.  Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease.

Authors:  S Kumar; R E Mansel; L E Hughes; J S Woodhead; C A Edwards; M F Scanlon; R G Newcombe
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

6.  Prognostic significance of prolactin receptors in human breast cancer.

Authors:  J Bonneterre; J P Peyrat; R Beuscart; J Lefebvre; A Demaille
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

7.  Thyroid hormone levels in human breast cyst fluid.

Authors:  A Angeli; L Dogliotti; F Agrimonti; R Faggiuolo; R Cavallo; A Tibo
Journal:  Acta Endocrinol (Copenh)       Date:  1984-10

Review 8.  Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.

Authors:  R J Santen; D Leszczynski; N Tilson-Mallet; P D Feil; C Wright; A Manni; S J Santner
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

9.  Prolactin and murine mammary tumorigenesis: a review.

Authors:  C W Welsch; H Nagasawa
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

10.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

Authors:  T Tanaka; R P Shiu; P W Gout; C T Beer; R L Noble; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

View more
  2 in total

1.  Effectiveness of Centchroman on Regression of Fibroadenosis and Mastalgia.

Authors:  Udayakumar Rajswaroob; Rajendiran Kannan; Narayanasamy Subbaraju Kannan; T Tirouaroul
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  A Randomized Pilot Study of Inositol in Association with Betaine and Boswellia in the Management of Mastalgia and Benign Breast Lump in Premenopausal Women.

Authors:  Vittorio Pasta; Simona Dinicola; Alessandro Giuliani; Abdel Halim Harrath; Saleh H Alwasel; Francesco Tartaglia; Alessandra Cucina; Mariano Bizzarri
Journal:  Breast Cancer (Auckl)       Date:  2016-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.